Clouding the G-7 gathering, which represents the world's major industrial economies, are the tit-for-tat tariffs between Washington and Beijing.Politicsread more
Hours after President Trump said Sunday he had "second thoughts" about escalating the trade war with China, the White House sought to explain his remark because it was...Politicsread more
President Donald Trump said that he would have a major trade deal with U.K. after it leaves the European Union.Politicsread more
Despite Kudlow's expectations, China said on Saturday that it strongly opposes Trump's decision to levy additional tariffs on $550 billion worth of Chinese goods, and warned...Politicsread more
President Donald Trump said Sunday he was not happy after North Korea launched short-range ballistic missiles over the weekend.Politicsread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
The announcement for Target also comes on the heels of a strong quarterly earnings report, where it showed it drove more people to stores and got them to spend more money...Retailread more
The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
Microsoft Corp.: "They reported a great quarter, but then, remember, what happened is we got caught up in some sort of tech battle. It's come back down. It's time to buy."
Alnylam Pharmaceuticals: "We have some biotech stocks that are down huge, like an Amgen, which my charitable trust owns. You can follow along by joining the ActionAlertsPlus.com club. I would much rather own Amgen down 20 straight points. That's your play. "
Golar LNG Limited: "No, too risky, too crazy. We're not going to go there anymore. We've got a whole natural gas situation going, but it's not necessarily anything I want you to pull the trigger on."
ResMed Inc.: "[CEO] Mick Farrell is sensational. They have done such a good job."
Pitney Bowes Inc.: "It's an $8 stock that has not proven itself. And I've got to tell you, when they haven't proven themselves long term, I am not going to get behind it. I will say this: if they want to come back on and they want to tell us why that last quarter looked pretty good, they are always going to be welcome. But I've got to tell you, it's been a real bad stock."
Disclosure: Cramer's charitable trust owns shares of Microsoft and Amgen.